A newly popular ingredient can be interesting and difficult to evaluate at the same time. C15:0 appears in conversations about cellular health, healthy aging and fatty acids. To decide how much weight to give those conversations, start by separating the ingredient itself from the different kinds of evidence surrounding it. A study can be informative without answering every question a shopper has.
What is C15:0?
C15:0 is pentadecanoic acid, an odd-chain saturated fatty acid. The name describes a chain of 15 carbon atoms with no carbon–carbon double bonds. It occurs in small amounts in some foods. Researchers have studied circulating C15:0 levels, its activity in laboratory systems and supplementation in people. These approaches provide different pieces of the picture.
A 2020 study in Scientific Reports investigated cellular activities and animal models and explored whether C15:0 might be an essential dietary fatty acid. This is a research hypothesis, not a reason to assume that every adult has a C15:0 deficiency or needs the same supplement dose.
Three questions to ask of any study
- Where was it tested? Cells in a laboratory, an animal model and people living their everyday lives are different settings.
- What was measured? A change in a blood marker is different from better daily functioning, fewer diagnoses or a longer life.
- What was compared? Observing people with higher blood levels is different from randomly assigning people to a supplement or placebo.
Mechanism studies can help explain why an ingredient deserves further investigation. They cannot, by themselves, tell you what taking a capsule will do for your energy, lifespan or long-term disease risk.
What a small human trial found
A randomized trial published in The Journal of Nutrition studied 30 young adults with overweight or obesity. Twenty received 200 mg of C15:0 daily and ten received placebo for 12 weeks. The primary question was whether supplementation would change circulating C15:0. It did: the increase was greater in the supplement group.
That is useful human evidence about the ingredient's effect on blood levels. The study also explored clinical markers, but its small size, short duration and specific participant group limit broader conclusions. Findings in subgroups do not establish that every participant—or every future customer—will have the same response. This trial did not demonstrate longer lifespan or prevention of cardiovascular disease, and it did not test RUOLAI's finished product.
Why observational findings need care
A 2026 analysis of the CARDIA and ARIC cohorts found modest associations between higher circulating C15:0 and some blood-pressure measures. However, it did not find an association with incident cardiovascular disease, and its genetic analyses did not support a causal cardiovascular benefit. Blood levels can be associated with an outcome without proving that taking a supplement produces that outcome.
This is why one favorable headline should not become a personal prediction. Reading the study design, measured endpoints and limitations together gives a more useful picture than collecting the most exciting sentence from each paper.
How to read a C15:0 label
Start with the ingredient name and amount per serving. Then read the serving size, number of servings and other ingredients. If a Daily Value has not been established, the label may say so; this does not mean the ingredient is a required daily nutrient or that the listed dose is a universal target. The FDA's labeling guide explains this distinction.
RUOLAI C15:0 lists 200 mg of pentadecanoic acid per one-capsule serving, with 60 capsules per bottle. The amount is easy to compare with a paper's dose, but matching an amount does not make two formulations identical or transfer a study's results to our product.
Make an informed place for it in your routine
Before adding another supplement, write down what you hope to achieve, what evidence supports that expectation and what remains uncertain. Review your full supplement list with a healthcare professional when deciding whether the ingredient is appropriate for you. Avoid treating an ingredient as a substitute for prescribed care or the basics of everyday nutrition.
View the RUOLAI C15:0 label and directions, or continue with our guide to comparing serving amounts.
About this guide
Prepared by RUOLAI to help you understand ingredients and labels. Ingredient research is distinct from testing a finished RUOLAI formula. Educational information, not personalized medical advice.
Sources & further reading
- Venn-Watson et al. (2020) — Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Scientific Reports
- Robinson et al. (2024) — Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of Nutrition
- Steffen et al. (2026) — Plasma pentadecanoic acid is modestly related to cardiovascular health in CARDIA and ARIC cohorts: observational associations without evidence of causality. Frontiers in Nutrition
- FDA — Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling
